Loading clinical trials...

RECRUITINGNCT06965374

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremor...

Lead sponsor: AbbVie•19 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Caterina Golotta

CONTACT

+39 06 548891 caterina.golotta@abbvie.com

Related studies

RECRUITING

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

NCT07642908 · Parkinson Disease

RECRUITINGPhase 2

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

NCT06680830 · Parkinson Disease, Parkinson, and more

RECRUITING

Cognitive Decline Following Deep Brain Stimulation

NCT05822388 · Parkinson Disease, Movement Disorders

RECRUITINGNA

Patient-Specific 3D Action Observation Training in Parkinson's Disease

NCT07250672 · Parkinson Disease, Virtual Reality, and more

RECRUITING

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

NCT06553625 · Parkinson Disease, Dystonia, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 13, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment270

Start dateJun 2025

Last updatedMay 13, 2026

Condition

Parkinson Disease

Locations shown

IRCCS Oasi SS. Troina /ID# 273507

Troina, Enna

Istituto Neurologico Mediterraneo Neuromed S.P.A. - Irccs /Id# 272695

Pozzilli, Isernia

ASST Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTO /ID# 272949

Milan, Milano

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 13, 2026Data synced to Clareo: June 27, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

What this study is about

Save this trial guide to your notes

Contacts

Sponsors

Related studies

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Cognitive Decline Following Deep Brain Stimulation

Patient-Specific 3D Action Observation Training in Parkinson's Disease

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Trial snapshot

Condition

Locations shown

For caregivers